TAF1L c.503A>G ;(p.D168G)

Variant ID: 9-32635075-T-C

NM_153809.2(TAF1L):c.503A>G;(p.D168G)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing.

Scientific Reports
Nanki, Yoshiko Y; Chiyoda, Tatsuyuki T; Hirasawa, Akira A; Ookubo, Aki A; Itoh, Manabu M; Ueno, Masaru M; Akahane, Tomoko T; Kameyama, Kaori K; Yamagami, Wataru W; Kataoka, Fumio F; Aoki, Daisuke D
Publication Date: 2020-07-28

Variant appearance in text: TAF1L: 503A>G
PubMed Link: 32724113
Variant Present in the following documents:
  • 41598_2020_69488_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page